Characteristic | Extended Survival | Poor Survival |
---|---|---|
No. of patients | 67 | 66 |
Age - years | 66.3 ± 1.2 | 65.3 ± 1.2 |
Male sex - no. (%) | 39 (58) | 49 (74) |
Year of surgery - no. (%) | ||
1991 | 0 (0) | 5 (7) |
1992 | 5 (7) | 6 (9) |
1993 | 6 (9) | 4 (6) |
1994 | 6 (9) | 7 (11) |
1999 | 50 (75) | 44 (67) |
Tumour stage - no. (%) | ||
1 | 40 (60) | 20 (30) |
2 | 18 (27) | 19 (29) |
3a | 9 (13) | 23 (35) |
3b and 4 | 0 (0) | 4 (6) |
Histology - no. (%) | ||
Squamous | 39 (58) | 29 (44) |
Adenocarcinoma | 19 (28) | 23 (35) |
Large cell | 4 (6) | 8 (12) |
Other | 5 (7) | 6 (9) |
Tumour Grade - no. (%) | ||
Well | 5 (7) | 2 (3) |
Moderate | 31 (46) | 17 (26) |
Poor | 30 (45) | 46 (70) |
Not recorded | 1 (1) | 1 (1) |
Adjuvant Chemotherapy (%) | 0 (0) | 2 (3) |
Radiotherapy (%) | 8 (12) | 12 (18) |
Palliative Radiotherapy (%) | 7 (10) | 9 (14) |
Survival - months | 84.0 ± 5.1 | 10.8 ± 0.8 |